F. Y. Kwong, A. S. C. Chan et al.
1
J=7.5 Hz, 2H), 2.72 (q, J=2.5 Hz, 2H), 1.75 (t, J=2.5 Hz, 3H),
1.24 ppm (t, J=7.5 Hz, 6H); 13C NMR (CDCl3, 125 MHz): d=169.9,
131.8, 119.3, 78.6, 73.2, 61.3, 56.8, 36.3, 22.7, 13.9, 3.3 ppm; IR (neat): n˜ =
3646, 3472, 3083, 2982, 2929, 2233, 1739, 1639, 1465, 1441, 1325, 1292,
1218, 1136, 1096, 1036, 912, 855, 661, 574 cmꢁ1; MS (EI): m/z (relative in-
tensity): 252 [M]+ (20), 194 (100).
ethyl acetate (2:1)); H NMR (CDCl3, 500 MHz): d=4.61 (q, J=15.5 Hz,
2H), 4.30–4.34 (m, 1H), 3.19–3.23 (m, 2H), 2.64–2.71 (dd, J=5.5,
18.0 Hz, 1H), 2.19–2.33 (m, 2H), 2.10–2.17 (dd, J=2.5, 18.0 Hz, 1H),
1.12 ppm (t, J=7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): d=208.0,
175.1, 138.6, 71.8, 64.8, 43.2, 38.6, 17.6, 16.3 ppm; MS (EI): m/z (relative
intensity): 152 [M]+, 100), 123 (40), 105 (50).
Catalytic asymmetric Pauson–Khand-type reaction:
2-(4-Methoxyphenyl)-7-oxabicyclo[3.3.0]oct-1-en-3-one
(Table 2,
entry 7):[12a] Purified by column chromatography (1.8ꢂ ꢀ15 cm) on silica
gel with hexane/ethyl acetate (2:1) as the eluent to obtain the title com-
pound as a light-yellow solid (93% yield; 93% ee): HPLC conditions: AS
column, Hex:IPA=9:1, 1.0 mLminꢁ1, 254 nm, Rt =15.9, 25.7 min; Rf =0.2
General procedure for asymmetric Pauson–Khand-type cyclization of
various enynes: [{Rh(cod)Cl}2] (4.4 mg, 9.0 mmol), (S)-P-Phos (11.6 mg,
18.0 mmol), and cinnamylaldehyde (59 mg, 0.45 mmol, 1.5 equiv with re-
spect to the enyne) were charged to a screw-cap vial on the bench top at
room temperature with continuous stirring (magnetic stirrer bar, 2ꢂ
6 mm). Enynes (0.3 mmol) was then added under air. These vials were
evacuated and backfilled with nitrogen (3 cycles) and this was followed
by addition of water (0.2 mL, concentration of enyne 1.5m). The reaction
mixtures were heated to 1008C (ꢂ28C) for 36 h (reaction times were un-
optimized for each substrate). The vials were allowed to cool to room
temperature. Ethyl acetate (ꢀ2 mL) was added and the crude product
was passed through a short plug of Na2SO4. Solvent was removed by
rotary evaporation and the crude mixture was purified by flash column
chromatography on silica gel with hexane/ethyl acetate as the eluent to
afford the chiral bicyclic cyclopentenones. (Alternative workup proce-
dure: dichloromethane (ꢀ2 mL) was added and the reaction mixture
was passed through a short plug of Na2SO4 for initial screening by GC-
MS analysis.) The enantiomeric excess values of the products were deter-
mined by chiral HPLC analysis with Daicel AS, AS-H, and AD-H col-
umns.
1
(hexane/ethyl acetate (2:1)); H NMR (CDCl3, 500 MHz): d=7.48 (d, J=
9.0 Hz, 2H), 6.93 (d, J=9.0 Hz, 1H), 4.89 (d, J=16.0 Hz, 1H), 4.57 (d,
J=16.0 Hz, 1H), 4.35 (t, J=8.0 Hz, 1H), 3.82 (s, 3H), 3.26–3.30 (m, 1H),
3.20 (dd, J=7.5, 11.0 Hz, 1H), 2.81 (dd, J=6.0, 17.5 Hz, 1H), 2.31 ppm
(dd, J=3.0, 17.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): d=202.3, 175.2,
159.8, 134.1, 129.3, 123.2, 114.0, 71.3, 66.3, 55.2, 43.1, 40.2 ppm; MS (EI):
m/z (relative intensity): 230 [M]+ (100), 201 (10), 189 (30), 172 (60).
2-(4-Methylphenyl)-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 6):
Purified by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with
hexane/ethyl acetate (3:1) as the eluent to obtain the title compound as a
white solid (92% yield; 87% ee): HPLC conditions: AS-H column,
Hex:IPA=9:1, 1.0 mLminꢁ1
,
254 nm, Rt =13.0, 18.5 min; Rf =0.4
(hexane/ethyl acetate (2:1)); [a]2D5 =+53.78 (c=0.010 in CHCl3);
1H NMR (CDCl3, 500 MHz): d=7.42 (d, J=8.0 Hz, 2H), 7.22 (d, J=
8.0 Hz, 1H), 4.93 (d, J=16.0 Hz, 1H), 4.59 (d, J=16.0 Hz, 1H), 4.37 (t,
J=7.5 Hz, 1H), 3.28–3.32 (m, 1H), 3.23 (dd, J=8.0, 11.5 Hz, 1H), 2.84
(dd, J=6.5, 17.5 Hz, 1H), 2.37 (s, 3H), 2.32 ppm (dd, J=3.5, 18.0 Hz,
1H); 13C NMR (CDCl3, 125 MHz): d=202.3, 175.2, 159.8, 134.1, 129.3,
123.2, 114.0, 71.3, 66.3, 43.1, 40.2, 23.8 ppm; IR (neat): n˜ =3020, 2397,
1747, 1511, 1419, 1215, 1040, 922, 756, 669 cmꢁ1; MS (EI): m/z (relative
intensity): 214 [M]+ (100), 184 (30), 169 (40), 156 (45), 141 (70); HRMS:
calcd for C14H14O2: 214.09938; found: 214.09943.
2-Phenyl-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 1):[9] Purified
by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with hexane/
ethyl acetate (3:1) as the eluent to obtain the title compound as a light
yellow oil (82% yield; 84% ee (S configuration)): HPLC conditions: AD
column, hexane (Hex):isopropyl alcohol (IPA)=9:1, 1.0 mLminꢁ1
,
254 nm, Rt =12.4, 16.9 min; Rf =0.3 (hexane/ethyl acetate (2:1));
1H NMR (CDCl3, 500 MHz): d=7.52 (d, J=7.5 Hz, 2H), 7.39–7.42 (m,
2H), 7.33–7.37 (m, 1H), 4.93 (d, J=16.5 Hz, 1H), 4.59 (d, J=16.0 Hz,
1H), 4.38 (t, J=8.0 Hz, 1H), 3.30–3.35 (m, 1H), 3.23 (dd, J=8.0 Hz,
11.5 Hz, 1H), 2.85 (dd, J=6.5 Hz, 18.5 Hz, 1H), 2.34 ppm (dd, J=4.0 Hz,
18.0 Hz, 1H); 13C NMR (CDCl3, 125 MHz): d=206.7, 177.3, 134.5, 130.5,
128.6, 128.5, 127.9, 71.2, 66.2, 43.2, 40.2 ppm; MS (EI): m/z (relative in-
tensity): 200 [M]+ (70), 170 (40), 158 (50), 141 (100).
2-Phenyl-5-methyl-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 2):[36]
Purified by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with
hexane/ethyl acetate (3:1) as the eluent to obtain the title compound as a
light yellow oil (71% yield; 90% ee): HPLC conditions: AS-H column,
Hex:IPA=9:1, 1.0 mLminꢁ1, 254 nm, Rt =9.7, 10.8 min; Rf =0.3 (hexane/
ethyl acetate (2:1)); 1H NMR (CDCl3, 500 MHz): d=7.33–7.51 (m, 5H),
4.98 (d, J=17.0 Hz, 1H), 4.60 (d, J=17.0 Hz, 1H), 4.03 (d, J=8.0 Hz,
1H), 3.43 (d, J=8.0 Hz, 1H), 2.60 (d, J=17.0 Hz, 1H), 2.54 (d, J=
17.0 Hz, 1H), 1.39 ppm (s, 3H); 13C NMR (CDCl3, 125 MHz): d=206.7,
180.6, 133.2, 130.5, 128.7, 128.6, 128.1, 76.5, 65.3, 48.7, 47.8, 24.7 ppm; MS
(EI): m/z (relative intensity): 214 [M]+ (80), 184 (20), 169 (40), 141 (100),
115 (70).
2-(4-Fluorophenyl)-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 7):
Purified by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with
hexane/ethyl acetate (3:1) as the eluent to obtain the title compound as a
light-yellow oil (90% yield; 82% ee): HPLC conditions: AS-H column,
Hex:IPA=98:2, 1.0 mLminꢁ1
, 254 nm, Rt =29.8, 35.7 min; Rf =0.3
(hexane/ethyl acetate (2:1)); [a]2D5 =+0.78 (c=0.0083 in CHCl3);
1H NMR (CDCl3, 500 MHz): d=7.52 (dd, J=5.5, 8.0 Hz, 2H), 7.09 (t,
J=8.0 Hz, 2H), 4.91 (d, J=16.5 Hz, 1H), 4.56 (d, J=16.5 Hz, 1H), 4.37
(t, J=7.5 Hz, 1H), 3.29–3.33 (m, 1H), 3.24 (dd, J=7.5, 11.0 Hz, 1H),
2.84 (dd, J=6.5, 18.0 Hz, 1H), 2.33 ppm (dd, J=3.5, 17.5 Hz, 1H);
13C NMR (CDCl3, 125 MHz): d=204.1, 177.0, 161.7, 133.6, 129.8 (d,
J
C,F =8.4 Hz), 126.7, 115.6 (d, JC,F =22.0 Hz), 71.3, 66.2, 43.2, 40.1 ppm;
IR (neat): n˜ =3021, 2392, 1701, 1506, 1215, 1029, 758, 669 cmꢁ1; MS (EI):
m/z (relative intensity): 218 [M]+ (70), 188 (50), 176 (50), 159 (100), 146
(60); HRMS: calcd for C13H11FO2: 218.07431; found: 218.07439.
2-(3-Methoxyphenyl)-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 8):
Purified by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with
hexane/ethyl acetate (3:1) as the eluent to obtain the title compound as a
light-yellow viscous oil (88% yield; 81% ee): HPLC conditions: AS-H
column, Hex:IPA=9:1, 1.0 mLminꢁ1, 254 nm, Rt =20.9, 47.0 min; Rf =0.3
(hexane/ethyl acetate (2:1)); [a]2D5 =+21.48 (c=0.011 in CHCl3);
1H NMR (CDCl3, 500 MHz): d=7.31 (t, J=7.5 Hz, 1H), 7.16 (s, 1H),
7.04 (d, J=8.0 Hz, 1H), 6.90 (dd, J=2.5, 8.0 Hz, 1H), 4.92 (d, J=
16.0 Hz, 1H), 4.59 (d, J=16.0 Hz, 1H), 4.37 (t, J=7.5 Hz, 1H), 3.82 (s,
3H), 3.29–3.33 (m, 1H), 3.23 (dd, J=7.5, 11.5 Hz, 1H), 2.84 (dd, J=6.5,
17.5 Hz, 1H), 2.33 ppm (dd, J=4.0, 17.5 Hz, 1H); 13C NMR (CDCl3,
125 MHz): d=206.7, 177.7, 159.6, 134.5, 131.8, 129.6, 120.5, 114.3, 113.4,
71.3, 66.3, 55.2, 43.3, 40.3 ppm; IR (neat): n˜ =3019, 2386, 1705, 1511,
1413, 1215, 1045, 1024, 922, 758, 669 cmꢁ1; MS (EI): m/z (relative intensi-
ty): 230 [M]+ (100), 213 (5), 199 (10), 185 (20), 171 (20), 159 (30);
HRMS: calcd for C14H14O3: 230.09430; found: 230.09422.
2-Methyl-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 3):[9] Purified
by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with hexane/
ethyl acetate (3:1) as the eluent to obtain the title compound as a color-
less oil (82% yield; 95% ee): HPLC conditions: AS-H column,
Hex:IPA=9:1, 1.0 mLminꢁ1
,
210 nm, Rt =12.2, 13.7 min; Rf =0.3
1
(hexane/ethyl acetate (2:1)); H NMR (CDCl3, 500 MHz): d=4.54 (q, J=
15.0 Hz, 2H), 4.30–4.32 (m, 1H), 3.19–3.23 (m, 2H), 2.64–2.71 (dd, J=
5.5, 18.0 Hz, 1H), 2.09–2.17 (dd, J=2.0, 18.0 Hz, 1H), 1.77 (s, 3H) ppm;
13C NMR (CDCl3, 125 MHz): d=209.0, 176.1, 132.6, 71.8, 64.7, 43.2, 38.6,
8.9 ppm; MS (EI): m/z (relative intensity): 138 [M]+ (100), 123 (60), 105
(30).
2-Ethyl-7-oxabicyclo[3.3.0]oct-1-en-3-one (Table 2, entry 4):[26] Purified
by column chromatography (1.8ꢂ ꢀ15 cm) on silica gel with hexane/
ethyl acetate (3:1) as the eluent to obtain the title compound as a color-
less oil (60% yield; 95% ee): HPLC conditions: AS-H column,
Hex:IPA=9:1, 1.0 mLminꢁ1, 210 nm, Rt =9.6, 11.7 min; Rf =0.3 (hexane/
2-(4-Chlorophenyl)-7-oxabicyclo[3.3.0]oct-1-en-3-one
(Table 2,
entry 9):[12a] Purified by column chromatography (1.8ꢂ ꢀ15 cm) on silica
gel with hexane/ethyl acetate (3:1) as the eluent to obtain the title com-
pound as a light-yellow oil (91% yield; 77% ee): HPLC conditions: AS-
3878
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 3872 – 3880